Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
CURRENT ASSETS
Cash and cash equivalents	$ 822	$ 227
Trade receivables, net of allowance for credit losses	2,993	6,337
Retention credit receivable	10	1,219
Notes receivable from related parties	5,501	5,251
Prepaid expenses and other current assets	442	430
Total current assets	9,768	13,464
Other intangible assets, net	3
Property, plant and equipment, net	15	26
Total assets	9,786	13,490
CURRENT LIABILITIES
Factoring liability	174	2,619
Accounts payable	548	698
Accrued expenses	290	339
Accrued payroll	637	981
Deferred revenue	206	176
Income taxes payable		6
Total current liabilities	1,855	4,819
Total liabilities	1,855	4,819
Commitment and contingencies (Note 9)
Subsequent events (Note 14)
STOCKHOLDERS’ EQUITY
Common stock, without par value, 300,000,000 shares authorized, 300,000,000 issued and outstanding as of December 31, 2023 and 2022
Additional paid-in capital	750	750
Retained earnings	7,181	7,921
Total stockholders’ equity	7,931	8,671
Total liabilities and stockholders’ equity	$ 9,786	$ 13,490